Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 1

1(25.0%)

4Total

N/A(3)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07064161Not ApplicableCompleted

Efficacy of Hydrocolloid Dressing vs. Topical Antibiotic on Wound Healing of Post-Punch Biopsy Wounds

Role: lead

NCT03138941Recruiting

Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region

Role: collaborator

NCT05701735Not ApplicableRecruiting

Decision Aid for Chemotherapy in Cisplatin-Intolerant Patients With Locally Advanced Cervical Cancer

Role: lead

NCT05210270Phase 1Not Yet Recruiting

HYpofractionated Pelvic Radiotherapy for Advanced Cervical Cancers INeligible for ChemoTherapy

Role: lead

NCT05484960Unknown

The Philippine Neurological Association One Database -Dementia

Role: collaborator

NCT04386083Unknown

Neurologic Manifestations of COVID-19

Role: collaborator

NCT03582592Not ApplicableCompleted

Fluid Distribution Timetable on Adherence to Fluid Restriction of Patients With End-Stage Renal Disease on Hemodialysis

Role: lead

All 7 trials loaded